Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RET-IN-10 is a potent inhibitor of RET, in which RET loss-of-function mutations cause congenital megacolon and its gain-of-function mutations are associated with a variety of human tumors. RET-IN-10 has shown research potential for cancer diseases.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約10-14 週間 | ¥ 349,000 |
50 mg | 約10-14 週間 | ¥ 454,500 |
100 mg | 約10-14 週間 | ¥ 574,000 |
説明 | RET-IN-10 is a potent inhibitor of RET, in which RET loss-of-function mutations cause congenital megacolon and its gain-of-function mutations are associated with a variety of human tumors. RET-IN-10 has shown research potential for cancer diseases. |
分子量 | 536.65 |
分子式 | C29H28N8OS |
CAS No. | 2662622-44-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
RET-IN-10 2662622-44-6 Inhibitor inhibitor inhibit